Agenda

Return

C. 57

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	July 27, 2021

Contra

Costa

County

Subject:

Contract #76-753 with DiaSorin, Inc

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 07/27/2021

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Jaspreet Benepal, 925-370-5101
cc:	Julia Santos Marcy Wilhelm F Carroll

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: July 27, 2021
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Health Services Director, or designee, to execute on behalf of the County Contract #76-753 with DiaSorin, Inc., a corporation, in an amount not to exceed $495,000, for the purchase and service of a Liaison XL Analyzer for specimen testing, and reagents for the Clinical Laboratory at the Contra Costa Regional Medical Center (CCRMC) and Contra Costa Health Centers, for the period from June 1, 2021 through May 31, 2026.

FISCAL IMPACT:

This contract will result in contractual service expenditures of up to $495,000 over a 5-year period and will be funded 100% by Hospital Enterprise Fund I revenues. (Rate increase)

BACKGROUND:

The CCRMC Clinical Laboratory uses DiaSorin for reagents and supplies for patient’s specimen testing and are specific to the analyzer used for testing. Among the tests conducted are those for measles, mumps, rubella and many others. DiaSorin, Inc. provides all the supplies needed for such testing. These tests are crucial for patients who suffer from various illnesses.

BACKGROUND: (CONT'D)

The Liaison XL Analyzer is fully automated chemiluminescence analyzer that performs complete sample processing and runs antigen-antibody assays. The purchase of the new machine will allow us to upgrade our systems and improve our efficiency in the immunoassay laboratories to assist with COVID-19.

The Product Supply Agreement obligates the County to indemnify DiaSorin for the modification of Products by the County, (iii) County’s failure to use Product in accordance with the labeling and Instructions for use supplied with the Product, or (iii) County’s negligence or willful misconduct.

Approval of this new contract #76-753 allows the contractor to provide services through May 31, 2026.

CONSEQUENCE OF NEGATIVE ACTION:

If this purchase order is not approved, then the CCRMC Clinical Laboratory will not be able to perform the specific patient testing that utilizes these supplies for COVID-19 testing, thus impacting patient safety and health.